Endocrine Gland Neoplasms  >>  oxaliplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00786058: A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Approved for marketing
3
Europe
OFF in experimental arm, Eloxatin, Calciumfolinat, 5-Fluorouracil
CONKO-Studiengruppe, Sanofi, medac GmbH, Amgen
Pancreatic Cancer
 
 
NCT01121848: Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Completed
3
108
Canada
Leucovorin, OXALIPLATIN, 5-Fluorouracil
Sanofi
Pancreatic Neoplasms
10/13
10/13

Download Options